SynopsisAdjuvant is an integral part of a vaccine that helps to develop strong immune response in the human body. Conventional vaccines are derived from toxin, inactivated whole organism, and live-attenuated, which are effective in stimulating antibody-based immunity......
Synopsis Due to the COVID-19 pandemic, the global Monitoring Electrodes market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully cons.....
SynopsisLV-based cell and gene therapy products refer to therapeutic products that utilize lentiviral vectors (LV) as a delivery system for introducing genetic material into target cells. Lentiviral vectors are commonly used in gene therapy to transfer genes into cell.....
SynopsisThe global Preloaded IOL Delivery System market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Preloaded IOL Delivery System is est.....
SynopsisThe global X-ray Stereotactic Radiosurgery System market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030. North American market for X-ray Stereotactic Radiosurg.....
SynopsisCardioplegia adapter is a specialized connector used in cardiac surgery to deliver cardioplegia solution (a cold, potassium-rich solution that stops the heart) to the coronary arteries, inducing temporary cardiac arrest during surgery. The global Cardiop.....
SynopsisWheeled Examination Lamp so constructed that an intense light is emitted through a slit; used for examination of the eye. The global Wheeled Examination Lamps market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witne.....
SynopsisPegfilgrastim is developed by PEGylating the recombinant human granulocyte colony-stimulating factor (G-CSF) analogue, filgrastim. Pegfilgrastim was first launched by Amgen Inc. as Neulasta in 2002. Later, several biosimilars of pegfilgrastim were launched in .....
SynopsisCRYSVITA is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 6 months of age and older. Market Analysis and Insights: Global Crysvita Market The global Crysvita market was valued at US$ XX in 202.....
Synopsis The global Blepharoplasty market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Blepharoplasty in various end use industries. The expanding .....
